Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovaBay Pharmaceuticals (NBY) Inventory Average (2016 - 2024)

NovaBay Pharmaceuticals (NBY) has disclosed Inventory Average for 12 consecutive years, with $586500.0 as the latest value for Q3 2024.

  • On a quarterly basis, Inventory Average fell 83.6% to $586500.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $586500.0, a 83.6% decrease, with the full-year FY2023 number at $2.0 million, down 40.84% from a year prior.
  • Inventory Average was $586500.0 for Q3 2024 at NovaBay Pharmaceuticals, down from $681500.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $3.9 million in Q3 2022 to a low of $522000.0 in Q1 2020.
  • A 5-year average of $1.9 million and a median of $825500.0 in 2021 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: soared 376.62% in 2022, then tumbled 83.91% in 2024.
  • NovaBay Pharmaceuticals' Inventory Average stood at $696500.0 in 2020, then soared by 200.72% to $2.1 million in 2021, then surged by 79.16% to $3.8 million in 2022, then tumbled by 46.78% to $2.0 million in 2023, then tumbled by 70.63% to $586500.0 in 2024.
  • Per Business Quant, the three most recent readings for NBY's Inventory Average are $586500.0 (Q3 2024), $681500.0 (Q2 2024), and $582000.0 (Q1 2024).